What is the immediate treatment for hyperkalemia?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 17, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Immediate Treatment for Hyperkalemia

The immediate treatment for hyperkalemia requires a three-step approach: cardiac membrane stabilization with intravenous calcium, shifting potassium into cells with insulin/glucose and albuterol, and eliminating potassium from the body through diuretics or dialysis. 1

Assessment of Severity

  • Hyperkalemia is classified as mild (5.0-5.9 mEq/L), moderate (6.0-6.4 mEq/L), or severe (≥6.5 mEq/L) 1, 2
  • ECG changes (peaked T waves, flattened P waves, prolonged PR interval, widened QRS) indicate urgent treatment regardless of potassium level 1, 2
  • Severe hyperkalemia (≥6.5 mEq/L) is life-threatening and requires immediate intervention 1

Step 1: Cardiac Membrane Stabilization

  • Administer intravenous calcium to protect the heart from arrhythmias:
    • Calcium chloride (10%): 5-10 mL (500-1000 mg) IV over 2-5 minutes, OR
    • Calcium gluconate (10%): 15-30 mL IV over 2-5 minutes 1, 2
  • Effects begin within 1-3 minutes but are temporary (30-60 minutes) 1
  • Important: Calcium does not lower serum potassium but protects against arrhythmias 1
  • Caution: In patients with malignant hyperthermia, calcium should only be used in extreme cases as it may contribute to calcium overload of the myoplasm 2

Step 2: Shift Potassium into Cells

  • Administer insulin with glucose:
    • 10 units regular insulin IV with 25g glucose (50 mL of D50W) over 15-30 minutes 1
    • Onset within 15-30 minutes, effect lasts 4-6 hours 1, 2
  • Add nebulized albuterol:
    • 10-20 mg over 15 minutes 1
    • Augments the effect of insulin/glucose 3
  • Consider sodium bicarbonate:
    • 50 mEq IV over 5 minutes 1
    • Most effective in patients with concurrent metabolic acidosis 1, 2
    • Promotes potassium excretion through increased distal sodium delivery 2

Step 3: Eliminate Potassium from Body

  • For patients with adequate renal function:
    • Loop diuretics (furosemide: 40-80 mg IV) 1, 2
  • For all patients:
    • Cation exchange resins (sodium polystyrene sulfonate/Kayexalate: 15-50 g orally or rectally with sorbitol) 1
    • Consider newer potassium binders (patiromer, sodium zirconium cyclosilicate) which are safer alternatives 1, 2
  • For severe hyperkalemia or renal failure:
    • Hemodialysis is the most effective method 1, 2

Important Clinical Considerations

  • Temporary measures (insulin/glucose, albuterol) provide only transient effects (1-4 hours); rebound hyperkalemia can occur after 2 hours 1
  • Monitor potassium levels closely during treatment to avoid overcorrection and hypokalaemia 1
  • Review and adjust medications that may contribute to hyperkalemia (ACE inhibitors, ARBs, MRAs, NSAIDs, beta-blockers) 1, 2
  • Patients with chronic kidney disease, heart failure, or diabetes are at higher risk for hyperkalemia and require more frequent monitoring 2, 4
  • For chronic hyperkalemia management, consider a multidisciplinary approach involving specialists and primary care physicians 2, 4

Common Pitfalls and Caveats

  • Failure to recognize ECG changes can lead to delayed treatment and cardiac complications 1, 5
  • Administering insulin without glucose can cause severe hypoglycemia, especially in malnourished patients 6
  • Relying solely on temporary measures without addressing elimination of potassium can lead to rebound hyperkalemia 1
  • Sodium polystyrene sulfonate can cause intestinal necrosis, particularly in postoperative patients or those with ileus 2, 6
  • Overcorrection of hyperkalemia can lead to hypokalaemia, which carries its own risks of arrhythmias 1

References

Guideline

Immediate Treatment for Hyperkalemia

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Hyperkalemia Management Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Management of hyperkalaemia.

The journal of the Royal College of Physicians of Edinburgh, 2013

Research

Hyperkalemia treatment standard.

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2024

Research

[The heart and hyperkalemia].

Archives des maladies du coeur et des vaisseaux, 1984

Research

Potassium Disorders: Hypokalemia and Hyperkalemia.

American family physician, 2015

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.